Advertisement

Respiratory Syncytial Virus Infection in Children

  • J. Hammer
  • C. J. L. Newth
Conference paper
  • 65 Downloads
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1997)

Abstract

Respiratory syncytial virus (RSV) is the major cause of viral respiratory tract infections in infants and children [1, 2]. The highly contagious nature of the virus means that essentially all children have been infected with RSV by 2 to 3 years of age. Epidemics principally occur in winter and early spring.

Keywords

Respiratory Syncytial Virus Respiratory Syncytial Virus Infection Bronchopulmonary Dysplasia Peak Inspiratory Pressure Congenital Heart Disease Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    La Via WV, Marks KI, Stutman HR (1992) Respiratory syncytial virus puzzle: Clinical features, pathophysiology, treatment and prevention. J Pediatr 121: 503–510Google Scholar
  2. 2.
    Glezen WP, Denny FW (1973) Epidemiology of acute lower respiratory disease in children. N Engl J Med 288: 498–505CrossRefPubMedGoogle Scholar
  3. 3.
    Henderson FW, Clyde WA Jr, Collier AM, et al (1979) The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr 95: 183–190CrossRefPubMedGoogle Scholar
  4. 4.
    Cradock-Watson JE, McQuillin J, Gardner PS (1970) Rapid diagnosis of respiratory syncytial virus infection in children by the immunofluorescent technique. J Clin Pathol 24: 308–312CrossRefGoogle Scholar
  5. 5.
    Stratton M, Ajizian SJ, Mitchell I, Newth CJL (1992) Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol 13: 143–150CrossRefGoogle Scholar
  6. 6.
    Groothuis JR, Gutierrez KM, Lauer BA (1988) Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 82: 199–203PubMedGoogle Scholar
  7. 7.
    Meert K, Heidemann S, Lieh-Lai M, Sarnaik AP (1989) Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised hosts. Pediatr Pulmonol 7: 167–170CrossRefPubMedGoogle Scholar
  8. 8.
    Hall CB, Powell KR, MacDonald NE, et al (1986) Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 315: 77–81CrossRefPubMedGoogle Scholar
  9. 9.
    Krasinksi K (1985) Severe respiratory syncytial virus infection: Clinical features, nosocomial acquisition and outcome. Pediatr Infect Dis 4: 250–257CrossRefGoogle Scholar
  10. 10.
    Moler FW, Khan AS, Meliones JN, Custer JR, Palmisano J, Shope TC (1992) Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: A recent experience. Crit Care Med 20: 1406–1413Google Scholar
  11. 11.
    Navas L, Wang E, De Carvalho V, Robinson J, and the Pediatric Investigators Collaborative Network on Infections in Canada (1992) Improved outcome of respiratory syncytial virus infection in a high risk hospitalized population of Canadian children. J Pediatr 121: 348–354Google Scholar
  12. 12.
    Hammer J, Newth CJL (1995) Infant pulmonary function testing in the Intensive Care Unit. Intensive Care Med 21: 744–752CrossRefPubMedGoogle Scholar
  13. 13.
    Hammer J, Numa A, Newth CJL (1995) Albuterol responsiveness in infants with respiratory failure due to RSV infection. J Pediatr 127: 485–490CrossRefPubMedGoogle Scholar
  14. 14.
    Hammer J, Numa A, Newth CJL (1996) ARDS triggered by RSV infection in infants. Intensive Care Med 22: S168 (Abst)Google Scholar
  15. 15.
    Tasker RC, Kiff K, Gordon I (1996) Severe respiratory syncytial virus-associatcd respiratory failure: Patterns of lower respiratory tract disease in young infants. Intensive Care Med 22: S184 (Abst)Google Scholar
  16. 16.
    Bernard GR, Artigas A, Brigham KL, et al (1994) The American-European Consensus Conference on ARDS. Definition, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818–824Google Scholar
  17. 17.
    Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138: 720–723PubMedGoogle Scholar
  18. 18.
    Stretton M, Deakers TW, Newth CJL (1992) Spirometry, lung mechanics and volumes during the acute phase of ARDS in pediatric patients. Am Rev Respir Dis 143: A248 (Abst)Google Scholar
  19. 19.
    Suter PM (1985) Assessment of respiratory mechanics in ARDS. In: Zapol WM, Falke K (eds) Acute respiratory failure. Marcel Dekker, New York, pp 507–519Google Scholar
  20. 20.
    Gattinoni L, Bombino M, Pelosi P, et al (1994) Lung structure and function in different stages of severe acute respiratory distress syndrome. JAMA 271: 1772–1779CrossRefPubMedGoogle Scholar
  21. 21.
    Gozal D, Colin AA, Jaffe M, et al (1990) Water, electrolyte, and endocrine hemostasis in infants with bronchiolitis. Pediatr Res 27: 204–209CrossRefPubMedGoogle Scholar
  22. 22.
    Deakers TW, Reynolds G, Stretton M, Newth CJL (1994) Cuffed endotracheal tubes in pediatric intensive care. J Pediatr 125: 57–62CrossRefPubMedGoogle Scholar
  23. 23.
    Outwater KM, Crone RK (1984) Management of respiratory failure in infants with acute viral bronchiolitis. Am J Dis Child 138: 1071–1075PubMedGoogle Scholar
  24. 24.
    Lebel MH, Gauthier M, Lacroix J, Rousseau E, Buithieu M (1989) Respiratory failure and mechanical ventilation in severe bronchiolitis. Arch Dis Child 64: 1431–1437CrossRefPubMedGoogle Scholar
  25. 25.
    Moler FW, Palmisano JM, Green TP, Custer JR (1993) Predictors of outcome of severe respiratory syncytial virus-associated respiratory failure treated with extracorporeal membrane oxygenation. J Pediatr 123: 46–52CrossRefPubMedGoogle Scholar
  26. 26.
    Steinhorn RH, Green TP (1990) Use of extracorporeal membrane oxygenation in the treatment of respiratory syncytial virus bronchiolitis: The national experience, 1983 to 1988. J Pediatr 116: 338–342CrossRefPubMedGoogle Scholar
  27. 27.
    Khan JY, Kerr SJ, Tometzki A, et al (1995) Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: A collaborative report. Arch Dis Child 73: F91–F94CrossRefGoogle Scholar
  28. 28.
    Newcomb RW (1989) Use of adrenergic bronchodilators by pediatric allergists and pulmonologists. Am J Dis Child 143: 481–485PubMedGoogle Scholar
  29. 29.
    Goodman TB, Chambers TL (1993) Bronchodilators for bronchiolitis. Lancet 341: 1380CrossRefPubMedGoogle Scholar
  30. 30.
    Schuh S, Canny G, Resiman JJ, et al (1990) Nebulized albuterol in acute bronchiolitis. J Pediatr 117: 633–637CrossRefPubMedGoogle Scholar
  31. 31.
    Klassen TP, Rowe PC, Sutcliffe T, Ross LJ, McDowell IW, Li MM (1991) Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 118: 807–811CrossRefPubMedGoogle Scholar
  32. 32.
    Alario AJ, Lewander WJ, Dennehy P, Seifer R, Mansell AL (1992) The efficacy of nebulized metaproterenol in wheezing infants and young children. Am J Dis Child 146: 412–418PubMedGoogle Scholar
  33. 33.
    Soto ME, Sly PD, Uren E, Taussig LM, Landau LI (1985) Bronchodilator response during acute viral bronchiolitis in infancy. Pediatr Pulmonol 2: 85–90CrossRefGoogle Scholar
  34. 34.
    Tepper RS, Rosenberg D, Eigen H, Reister T (1994) Bronchodilator responsiveness in infants with bronchiolitis. Pediatr Pulmonol 17: 81–85CrossRefPubMedGoogle Scholar
  35. 35.
    Tal A, Sanchez I, Pasterkamp H (1991) Respirosonography in infants with acute bronchiolitis. Am J Dis Child 145: 1405–1410PubMedGoogle Scholar
  36. 36.
    Sly PD, Lanteri CJ, Raven JM (1991) Do wheezy infants recovering from bronchiolitis respond to salbutamol? Pediatr Pulmonol 10: 36–39CrossRefPubMedGoogle Scholar
  37. 37.
    Wang EEL, Milner R, Allen U, Maj H (1992) Bronchodilators for treatment of mild bronchiolitis: A factorial randomized trial. Arch Dis Child 67: 289–293Google Scholar
  38. 38.
    Sanchez I, De Koster J, Powell RE, Wolstein R, Chernick V (1993) Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 122: 145–151CrossRefPubMedGoogle Scholar
  39. 39.
    Hughes DM, LeSouëf PN, Landau LI (1987) Effect of salbutamol on respiratory mechanics in bronchiolitis. Pediatr Res 22: 83–86CrossRefPubMedGoogle Scholar
  40. 40.
    Stokes GM, Milner AD, Hodges GC, Henry RL, Elphick MC (1983) Nebulised therapy in acute severe bronchiolitis in infancy. Arch Dis Child 58: 279–283CrossRefPubMedGoogle Scholar
  41. 41.
    Rutter N, Milner AD, Hiller EJ (1975) Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezing bronchitis. Arch Dis Child 50: 719–722CrossRefPubMedGoogle Scholar
  42. 42.
    Ho L, Collis G, Landau LI, LeSouëf PN (1991) Effect of salbutamol on oxygen saturation on bronchiolitis. Arch Dis Child 66: 1061–1064CrossRefPubMedGoogle Scholar
  43. 43.
    Prendiville A, Green A, Silverman M (1987) Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax 42: 86–91CrossRefPubMedGoogle Scholar
  44. 44.
    O’Callaghan C, Milner AD, Swarbrick A (1986) Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet 2: 1424–1425CrossRefPubMedGoogle Scholar
  45. 45.
    Sanchez I, De Koster J, Powell RE, Wolstein R, Chernick V (1993) Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 122: 145–151CrossRefPubMedGoogle Scholar
  46. 46.
    Newth CJL, Amsler B, Anderson GP, Morley J (1991) The ventilatory and oxygen costs in the anesthetized rhesus monkey of inhaling drugs used in the therapy and diagnosis of asthma. Am Rev Respir Dis 143: 766–771PubMedGoogle Scholar
  47. 47.
    Tal A, Pasterkamp H, Leahy F (1984) Arterial oxygen desaturation following salbutamol inhalation in acute asthma. Chest 86: 868–869CrossRefPubMedGoogle Scholar
  48. 48.
    Patel NR, Nichani S, Hammer J, Numa A, Newth CJL (1996) The effect of inhaled nitric oxide on respiratory mechanics in intubated infants with severe RSV bronchiolitis. Am J Respir Crit Care Med 153: A502 (Abst)Google Scholar
  49. 49.
    Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP (1994) Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 124: 881–888CrossRefPubMedGoogle Scholar
  50. 50.
    Leclerc F, Riou Y, Martinot A, et al (1994) Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia. Intensive Care Med 20: 511–512CrossRefPubMedGoogle Scholar
  51. 51.
    Thompson MW, Bates JN, Klein JM (1995) Treatment of respiratory failure in an infant with bronchopulmonary dysplasia with respiratory syncytial virus using inhaled nitric oxide and high frequency ventilation. Acta Paediatr 84: 100–102CrossRefPubMedGoogle Scholar
  52. 52.
    Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R (1996) Dexamethasone in bronchiolitis: A randomized, controlled trial. Lancet 348: 292–295Google Scholar
  53. 53.
    Law BJ, De Carvalho V and the Pediatric Investigators Collaborative Network on Infections in Canada (1993) Respiratory syncytial virus infections in hospitalized Canadian children: Regional differences in patient populations and management practices. Pediatr Infect Dis J 12: 659–663Google Scholar
  54. 54.
    Hall CB, McBride JT, Walsh EE, et al (1983) Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection. N Engl J Med 308: 1443–1447CrossRefPubMedGoogle Scholar
  55. 55.
    Taber LH, Knight V, Gilbert BE, et al (1983) Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 72: 613–618PubMedGoogle Scholar
  56. 56.
    Hall CB, McBride JT, Gala CL, Hildreth SW, Schnabel KC (1985) Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA 254: 3047–3051CrossRefPubMedGoogle Scholar
  57. 57.
    Groothuis JR, Woodlin KA, Katz R, et al (1990) Early ribavirin treatment of respiratory syncytial viral infection in high risk children. J Pediatr 117: 792–798CrossRefPubMedGoogle Scholar
  58. 58.
    Smith DW, Frankel LR, Mathers LH, Tang ATS, Ariagno RL, Prober CG (1991) A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 325: 24–29CrossRefPubMedGoogle Scholar
  59. 59.
    Mitchell I, Joffe A, Newth CJL (1996) Ribavirin: Red Book Committee recommendations questioned (letter). Pediatrics 95: 319–320Google Scholar
  60. 60.
    Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW (1994) Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A prospective, double-blind, randomized trial. Crit Care Med 22: 566–572Google Scholar
  61. 61.
    Moler FW, Steinhart CM, Ohmit SE, Stidham GL, and the Pediatric Critical Care Study Group (1996) Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. J Pediatr 128: 422–428Google Scholar
  62. 62.
    American Academy of Pediatrics (1996) Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infection. Pediatrics 97: 137–140Google Scholar
  63. 63.
    Moler FW, Khan AS, Meliones JN, Custer JR, Palmisano J, Shope TC (1991) Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: A recent experience. Crit Care Med 20: 1406–1413Google Scholar
  64. 64.
    Timmons OD, Haynes PL, Fackler JC (1995) Predicting death in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Extracorporeal Life Support Organization. Chest 108: 789–797Google Scholar
  65. 65.
    Davis SL, Fuhrman DP, Costarino AT (1993) Adult respiratory distress syndrome in children: Associated disease, clinical course, and predictors of death. J Pediatr 123: 35–45Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • J. Hammer
  • C. J. L. Newth

There are no affiliations available

Personalised recommendations